Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024:1448:601-609.
doi: 10.1007/978-3-031-59815-9_40.

Other Immunomodulatory Treatment for Cytokine Storm Syndromes

Ezgi Deniz Batu  1 , Seza Ozen  1
Affiliations
Review

Other Immunomodulatory Treatment for Cytokine Storm Syndromes

Ezgi Deniz Batu et al. Adv Exp Med Biol. 2024.

Abstract

Cytokine storm syndromes (CSS) include different entities such as macrophage activation syndrome, primary and secondary hemophagocytic lymphohistiocytosis (HLH), and multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. An effective management strategy is critical in CSS. While biologics have become an essential part of CSS treatment, hematopoietic stem cell transplantation (HSCT) has changed the fate of primary HLH patients. This chapter will focus on the available alternative immunomodulatory therapies in CSS, which include corticosteroids, cyclosporine A, intravenous immunoglobulin, interleukin 18 binding protein, therapeutic plasmapheresis, HSCT, and mesenchymal stromal cell-based therapies.

Keywords: Anti-thymocyte globulin; Intravenous immunoglobulin; Plasmapheresis; Rituximab.

PubMed Disclaimer

References

    1. Tothova Z, Berliner N. Hemophagocytic syndrome and critical illness: new insights into diagnosis and management. J Intensive Care Med. 2015;30(7):401–12. - PubMed - DOI
    1. Batu ED. Glucocorticoid treatment in juvenile idiopathic arthritis. Rheumatol Int. 2019;39(1):13–27. - PubMed - DOI
    1. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31. - PubMed - DOI
    1. Boom V, Anton J, Lahdenne P, Quartier P, Ravelli A, Wulffraat NM, et al. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2015;13:55. - PubMed - PMC - DOI
    1. Quartier P. Systemic juvenile idiopathic arthritis/pediatric Still’s disease, a syndrome but several clinical forms: recent therapeutic approaches. J Clin Med. 2022;11(5):1357. - PubMed - PMC - DOI

MeSH terms

Supplementary concepts

LinkOut - more resources